title: Reply to fernández-ruiz et Al.:  immune defect in patients with epstein-barr virus reactivation after allogeneic hematopoietic stem cell transplantation.
authors: Marie
authors: M
authors: Robin
authors: Régis
authors: R
authors: de Latour
authors: Aliénor
authors: A
authors: Xhaard
authors: Gérard
authors: G
authors: Socié
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D004854:Herpesvirus 4, Human / Q000187:drug effects*; D006801:Humans; D007239:Infections / Q000453:epidemiology*; D008297:Male; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived